Skip to content

Clinical trials

Phase 2 Heart Failure trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 2 Country / region: Czechia Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20102
20112
20133
20141
20161
20172
20181
20201
20211
20222
20233
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated7
Recruiting2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
AstraZeneca2
Bristol-Myers Squibb2
Cardurion Pharmaceuticals, Inc.2
Novartis Pharmaceuticals2
Pfizer2
University Hospital Ostrava2
Akros Pharma Inc.1
Cardior Pharmaceuticals GmbH1
Cytokinetics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure28
Cardiovascular Diseases2
Diabetes Mellitus, Type 22
Heart Diseases2
Renal Insufficiency, Chronic2
Diabetes Mellitus1
Diabetic Nephropathies1
Dyspnea1
Heart Failure, Diastolic1
Hyperglycemia1

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.